Rubedo Life Sciences
PrivateLast Round
Series A
Apr 22, 2024
Total Funding Raised
$53.45M
Company Overview
Rubedo Life Sciences operates in Healthcare & Life Sciences and is based in Sunnyvale, California. Its latest recorded funding round was a Series A round in April 2024.
Rubedo Life Sciences is a biopharmaceutical company that develops therapies for chronic age-related diseases by targeting senescent cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rubedo Life Sciences Comparables
Compare Rubedo Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deciduous Therapeutics | 89% | |
| Cleara Biotech | 84% | |
| StarkAge Therapeutics | 82% |
For institutional investors. Book with your work email.
Rubedo Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 22, 2024 | ||||
| Grant | Feb 6, 2023 | ||||
| Seed | Dec 3, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rubedo Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Seed, Series A |
| Khosla Ventures | Seed, Series A |
| age1 | Seed |
| Hevolution Foundation | Series A |
| LongeVC | Series A |
| Longevity Fund | Seed |
| California Institute for Regenerative Medicine | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 22, 2025
First patient dosed in Phase 1 trial for RLS-1496.
- Jan 1, 2025
Presented at the 12th Annual Dermatology Summit.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 16, 2026
Rubedo Life Sciences, Inc. announces experimental skin cream RLS-1496, which shows preliminary results reducing biological age by two years, clearing senescent cells, and boosting collagen production by 10%.
- receives_awardSep 22, 2026
In 2026, Prix Galien USA named Rubedo Life Sciences, Inc. one of the finalists for the Best Startup Award.
- recognized_asSep 22, 2026
Rubedo Life Sciences, Inc. was named one of the finalists for the Prix Galien USA Best Startup award in 2026.
For institutional investors. Book with your work email.
Rubedo Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rubedo Life Sciences's valuation, stock price, and market status.
Is Rubedo Life Sciences a public or private company?
Rubedo Life Sciences is a private company.
What is the current stock price of Rubedo Life Sciences?
Rubedo Life Sciences is a private company, so its shares have no public market price. Caplight tracks Rubedo Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rubedo Life Sciences worth (valuation)?
Valuation information for Rubedo Life Sciences is not publicly available.
Can I buy Rubedo Life Sciences stock?
Rubedo Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rubedo Life Sciences's last funding round?
Rubedo Life Sciences's most recent funding round was Series A on April 22, 2024.
Who are the main investors in Rubedo Life Sciences?
Key investors in Rubedo Life Sciences include Khosla Ventures, Ahren Innovation Capital.
Will Rubedo Life Sciences IPO soon?
No public IPO plans have been announced for Rubedo Life Sciences.
How can I track Rubedo Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Rubedo Life Sciences's shares on secondary markets.